Medicine recall – Valsartan; Actavis and Dexcel brands
July 6, 2018
Please be aware that pharmacy has been notified of a class 1 (immediate action) recall on Valsartan branded products (Actavis and Dexcel tablets and capsules). The recall is due to possible chemical contamination.
The affected products are:
| Product name | marketing authorisation holder | PL number |
| Valsartan 40mg capsules, hard | Dexcel pharma limited | PL 14017/0192 |
| Valsartan 80mg capsules, hard | Dexcel pharma limited | PL 14017/0193 |
| Valsartan 160mg capsules, hard | Dexcel pharma limited | PL 14017/0194 |
| Valsartan 40mg film-coated tablets | Actavis group ptc ehf | PL 30306/0109 |
| Valsartan 80mg film-coated tablets | Actavis group ptc ehf | PL 30306/0110 |
| Valsartan 160mg film-coated tablets | Actavis group ptc ehf | PL 30306/0111 |
| Valsartan 320mg film-coated tablets | Actavis group ptc ehf | PL 30306/0405 |
Pharmacy can confirm it does not have the affected products.
Please be aware, patients may present to us with the affected products and we may be using their supply of affected products on wards (patient’s own drugs). All nursing and medical colleagues are urged to check with patients who either are prescribed Valsartan, or who have Valsartan on the drug histories (which can be seen as the green drug history form in the patient’s case notes) if they have the affected products.
If affected products are found, please remove them immediately and quarantine them. Inform pharmacy immediately (out of hours through the on-call pharmacist) and we will remove the products and organise a supply of unaffected product (the following day if out of hours).
For further information, please visit gov.uk or contact Medicines Information on ext. 5259.